Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Inoue

Showing results (831-840 of 847) with videos related to

Pageof 85
Sort By:
BMC Medicine|July 12, 2018
Optimising first- and second-line treatment strategies for untreated major depressive disorder - the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trialTadashi Kato, Toshi A Furukawa, Akio Mantani, et al.
Journal of Thrombosis and Thrombolysis|May 28, 2025
Edoxaban treatment without initial heparin lead-in for acute venous thromboembolism: insight from the COMMAND VTE registry-2Yuta Tsujisaka, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 2, 2025
Prediction Score for Major Bleeding in Patients With Venous Thromboembolism Receiving Direct Oral Anticoagulants - Insights From the COMMAND VTE Registry-2Satoshi Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.
Research and Practice in Thrombosis and Haemostasis|August 12, 2025
Differences in risk factors between all-cause and pulmonary embolism-related death in acute pulmonary embolism: insights from the COMMAND VTE registry-2Soichiro Kobayashi, Yoshito Ogihara, Yugo Yamashita, et al.
Thrombosis Research|March 10, 2024
Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2Yoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 23, 2024
Association Between White Blood Cell Counts at Diagnosis and Clinical Outcomes in Venous Thromboembolism - From the COMMAND VTE Registry-2Shinya Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.
Thrombosis Research|April 23, 2024
Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysisShinya Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.
Thrombosis Research|January 8, 2024
Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, et al.
Research and Practice in Thrombosis and Haemostasis|December 5, 2024
Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2Toru Sato, Yoshito Ogihara, Yugo Yamashita, et al.
Journal of Thrombosis and Thrombolysis|May 18, 2024
Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2Hiroshi Mabuchi, Ryusuke Nishikawa, Yugo Yamashita, et al.
Pageof 85

Showing results (831-840 of 847) with videos related to

Sort By:
Pageof 85
BMC Medicine|July 12, 2018
Optimising first- and second-line treatment strategies for untreated major depressive disorder - the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trialTadashi Kato, Toshi A Furukawa, Akio Mantani, et al.
Journal of Thrombosis and Thrombolysis|May 28, 2025
Edoxaban treatment without initial heparin lead-in for acute venous thromboembolism: insight from the COMMAND VTE registry-2Yuta Tsujisaka, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 2, 2025
Prediction Score for Major Bleeding in Patients With Venous Thromboembolism Receiving Direct Oral Anticoagulants - Insights From the COMMAND VTE Registry-2Satoshi Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.
Research and Practice in Thrombosis and Haemostasis|August 12, 2025
Differences in risk factors between all-cause and pulmonary embolism-related death in acute pulmonary embolism: insights from the COMMAND VTE registry-2Soichiro Kobayashi, Yoshito Ogihara, Yugo Yamashita, et al.
Thrombosis Research|March 10, 2024
Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2Yoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 23, 2024
Association Between White Blood Cell Counts at Diagnosis and Clinical Outcomes in Venous Thromboembolism - From the COMMAND VTE Registry-2Shinya Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.
Thrombosis Research|April 23, 2024
Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysisShinya Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.
Thrombosis Research|January 8, 2024
Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, et al.
Research and Practice in Thrombosis and Haemostasis|December 5, 2024
Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2Toru Sato, Yoshito Ogihara, Yugo Yamashita, et al.
Journal of Thrombosis and Thrombolysis|May 18, 2024
Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2Hiroshi Mabuchi, Ryusuke Nishikawa, Yugo Yamashita, et al.
Pageof 85